Celltrion Pharm

068760.KQ

27.46 USD

-0.05

-0.18%

Overview

Last close

27.46 usd

Market cap

1.22B usd

52 week high

52.45 usd

52 week low

25.63 usd

Target price

101.99 usd

Valuation

P/E

62.5801

Forward P/E

49.505

Price/Sales

5.9042

Price/Book Value

3.611

Enterprise Value

1.24B usd

EV/Revenue

2.8692

EV/EBITDA

19.3793

Key financials

Revenue TTM

206.03M usd

Gross Profit TTM

60.63M usd

EBITDA TTM

32.09M usd

Earnings per Share

0.44 usd

Dividend

0.15 usd

Total assets

503.50M usd

Net debt

58.35M usd

About

Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncology, and other drugs. It serves university hospitals and general pharmacies. Celltrion Pharm Inc. was founded in 1976 and is based in Cheongju-si, South Korea. Celltrion Pharm, Inc. (KOSDAQ:A068760) operates as a subsidiary of Celltrion, Inc.